Company Comparison
ContralinePioneering male birth control vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | ContralinePioneering male birth control | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Charlottesville, VA | South San Francisco, California |
| Founded | 2015 | 2006 |
| Status | Active | Active |
| Last Funding Stage | Series A | — |
| Total Funding | $23M | — |
| Valuation | — | — |
What They Build
ContralinePioneering male birth control
Biotechnology company developing innovative male contraceptive solutions including non-hormonal birth control methods.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
ContralinePioneering male birth control
Sector Overlap
Both ContralinePioneering male birth control and 23andMe operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.